Annual report pursuant to Section 13 and 15(d)

STATEMENTS OF OPERATIONS

v3.24.0.1
STATEMENTS OF OPERATIONS - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Operating expenses:    
Research and development $ 40,513 $ 62,475
Research and development - licenses acquired 527 1,474
Gain on the sale of property and equipment (1,466)  
General and administrative 9,686 12,210
Total operating expenses 49,260 76,159
Loss from operations (49,260) (76,159)
Other income (expense)    
Other income 917 1,304
Interest income 850 689
Interest expense (4,109) (3,359)
Total other income (expense) (2,342) (1,366)
Net Loss $ (51,602) $ (77,525)
Net loss per common share outstanding, basic $ (6.00) $ (10.09)
Net loss per common share outstanding, diluted $ (6.00) $ (10.09)
Weighted average number of common shares outstanding, basic 8,604,104 7,684,508
Weighted average number of common shares outstanding, diluted 8,604,104 7,684,508